This inventor holds 10 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Serpin Pharma, LLC, American Type Culture Collection, Caerus Therapeutics, Inc.. Active years: 2011-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nokesville, VA (US) (2011 - 2023)
- Manassas, VA (US) (2023)
Company Filing History:
7 out of 7 
2 out of 5 
1 out of 1 Years Active: 2011-2025
Title: The Innovative Contributions of Cohava Gelber
Introduction
Cohava Gelber is a prominent inventor residing in Nokesville, Virginia, renowned for his significant contributions to the fields of biotechnology and medicine. With a remarkable portfolio of 10 patents, Gelber's work primarily focuses on the development of peptides for therapeutic applications, particularly in addressing autoimmune, inflammatory, and metabolic diseases.
Latest Patents
Among his most recent patents, Gelber has developed groundbreaking innovations such as "Serpin peptides and methods of using the same," which details peptides designed for treating various autoimmune and inflammatory conditions. Another notable patent is titled "Peptides and methods of using the same," which describes SERPIN peptides, their analogues, and derivatives, highlighting their applications in treating conditions associated with LRP1 mediation. These patents underscore Gelber's dedication to advancing medical treatments through innovative peptide design.
Career Highlights
Throughout his career, Cohava Gelber has collaborated with reputable organizations, including Serpin Pharma, LLC and the American Type Culture Collection. His role in these companies has allowed him to leverage his expertise in peptide technology and contribute to valuable research initiatives aimed at developing novel therapeutics.
Collaborations
Gelber’s journey in the innovative landscape has also been shaped by partnerships with talented colleagues such as Soren Mogelsvang and Liping Liu. These collaborations have played a crucial role in fostering an environment of creativity and knowledge exchange, further enhancing the impact of their collective research endeavors.
Conclusion
Cohava Gelber’s innovative work and patented inventions continue to influence the field of biotechnology significantly. His dedication to advancing peptide research offers hope for new treatment modalities for a range of diseases, positioning him as a notable figure in the landscape of modern medicine. As he forges ahead in his career, the scientific community eagerly anticipates the future contributions of this visionary inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile